Articles by Mary Grecco
Cancer organoid-based drug sensitivity tests have recently been investigated to predict responses to anticancer drugs.
Role of MicroRNAs on Anti-Apoptotic MCL-1/cIAP-2 Gene Expression in Patients With EGFR-Mutated NSCLC
A study that assessed the impact of miR-29a and miR-143 on gene expression in lung cancer.
Patient-derived organoids have shown promise in modeling cancer therapy response.
A study that examined whether the combination of AI and knowledge can identify more patients with lung and ovarian cancers.
A study examined whether AI and clinical knowledge can identify more patients with lung and ovarian cancers.
A study detailed the landscape of lung adenocarcinoma progression.
MK-1084 as monotherapy and in combination with pembrolizumab is effective in patients with NSCLC.
A study explored the potential benefits of combining first-generation EGFR-TKI with chemotherapy as neoadjuvant treatment.
Chemotherapy-induced myelosuppression among patients with extensive-stage SCLC is poorly understood.
The VISION study that evaluated pre/post-tepotinib treatment in advanced/metastatic METex14 skipping NSCLC.
The DeLLphi-301 study that evaluated patients with advanced SCLC.
Results of a study that evaluated the impact of comprehensive versus limited NGS for advanced NSCLC.
A study evaluated second-line treatment patterns and clinical outcomes of IO in NSCLC.
Patients with metastatic NSCLC who receive first-line anti-PD-L1-based IO may achieve durable disease control.
Lurbinectedin monotherapy is currently being studied in Jazz EMERGE 402 study in patients with metastatic SCLC.
Black and/or socioeconomically disadvantaged patients with advanced NSCLC have higher mortality rates.
Results of a lung screening program found a significantly higher lung cancer prevalence in veterans.
A greater understanding of patients with HER2-mutated NSCLC is critical for developing therapies.
A study analyzed the cost-effectiveness of two different treatment methods in NSCLC.
Results of a study explored the potential of automated lung tumor vascularity.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.